Boryung Pharmaceutical Co., Ltd: all 143 studies

Page 2 of 2. Open to participants first (23), then studies with results posted, then the rest; newest registration first within each.

• The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult VolunteersCompletedNCT02581696Phase 1
• A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/RosuvastatinCompletedNCT02569814Phase 1
• A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination TabletCompletedNCT02566187Phase 1
• Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis VaccineinjCompletedNCT02532569Phase 4
• Fimasartan Achieving SBP Target (FAST) StudyCompletedNCT02495324Phase 4
• A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male VolunteersCompletedNCT02493738Phase 1
• Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruSCompletedNCT02458183Phase 3
• Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male VolunteersCompletedNCT02397590Phase 1
• Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male SubjectsCompletedNCT02397538Phase 1
• Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient(Kanarb-Hypertension Epidemiology Medication Satisfaction Study)CompletedNCT02394392
• A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/HydrochlorothiazideCompletedNCT02222480Phase 2
• to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and RosuvastatinCompletedNCT02205190Phase 1
• To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual TabletsCompletedNCT02205151Phase 1
• A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and DyslipidemiaCompletedNCT02166814Phase 3
• Fimasartan/Amlodipine Combination Phase IIICompletedNCT02152306Phase 3
• Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSionCompletedNCT02022774
• To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and RosuvastatinCompletedNCT01921946Phase 1
• A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential HypertensionCompletedNCT01878201Phase 2
• Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive PatientsCompletedNCT01736488Phase 4
• A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential HypertensionCompletedNCT01672476Phase 3
• Clinical Trials for Single Oral Dose of 60mg Fimasartan and Single IV Infusion of 30mg Fimasartan to Evaluate the Absolute Bioavailability of Kanarb® Tablet (Fimasartan) in Healthy SubjectsCompletedNCT01671020Phase 1
• A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential HypertensionCompletedNCT01518998Phase 2
• Pharmacokinetics of Megace F and Megace OS Under Fasting and Fed Conditions in Healthy Male VolunteersCompletedNCT01397214Phase 1
• Fimasartan (BR-A-657) Multiple Oral Dose in Healthy SubjectsCompletedNCT01289899Phase 1
• Fimasartan (BR-A-657) Single Oral Dose in Healthy SubjectsCompletedNCT01289886Phase 1
• A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapyCompletedNCT01258673Phase 3
• Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in KoreaCompletedNCT01150942Phase 3
• A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy VolunteersCompletedNCT01148368Phase 1
• A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy VolunteersCompletedNCT01146938Phase 1
• The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential HypertensionCompletedNCT01135212Phase 3
• A Study to Assess Food Effect on the Pharmacokinetics of Fimasartan in Healthy Male VolunteersCompletedNCT01007409Phase 1
• A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male VolunteersCompletedNCT00991783Phase 1
• A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male VolunteersCompletedNCT00991705Phase 1
• A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male VolunteersCompletedNCT00938262Phase 1
• A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male VolunteersCompletedNCT00938197Phase 1
• A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male VolunteersCompletedNCT00938132Phase 1
• Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K)CompletedNCT00937651Phase 2
• Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male VolunteersCompletedNCT00937534Phase 1
• Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension PatientsCompletedNCT00923611Phase 2
• A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male VolunteersCompletedNCT00923533Phase 1
• Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive PatientsCompletedNCT00386529Phase 4
• The Effects of Cilnidipine on Metabolic Syndrome ImprovementCompletedNCT00325936Phase 4
• Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With HypertensionCompletedNCT00325637Phase 3

← Boryung Pharmaceutical Co., Ltd overview and focus areas